Targeting Apoptosis-Resistant Proliferation: Imatinib-Based Combinations Induce Durable Cytostatic Arrest in 3D...

Area of Science:

• Oncology
• Cell Biology
• Pharmacology

Background:

• Endometrial cancer often develops resistance to apoptosis-based therapies.
• Alternative strategies controlling tumor growth independently of cell death are needed.
• Three-dimensional (3D) tumor models better mimic in vivo conditions than 2D cultures.

Purpose of the Study:

• To evaluate imatinib-based combination treatments in a 3D endometrial cancer model.
• To assess the potential for sustained cytostatic responses.
• To investigate therapeutic strategies independent of apoptosis induction.

Main Methods:

• Ishikawa spheroids were treated with imatinib alone or combined with lithium chloride or medroxyprogesterone acetate.
• Proliferation was measured using bromodeoxyuridine incorporation.
• Cell cycle distribution and apoptosis were analyzed via flow cytometry and Annexin V/propidium iodide staining.

Main Results:

• Imatinib monotherapy showed limited antiproliferative effects.
• Combination treatments significantly suppressed DNA synthesis and increased G0/G1 cell cycle accumulation.
• Sustained growth inhibition occurred with minimal induction of apoptosis.

Conclusions:

• Imatinib-based combinations primarily induce cytostatic effects through cell cycle arrest in 3D endometrial cancer models.
• This approach targets apoptosis-resistant proliferation, offering a complementary strategy.
• Further translational studies are warranted for hormone-responsive endometrial cancer.